Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -44.21% is 27% below its 5-year average of -34.92%, around the middle of its 5-year range (-57.02%–-20.13%).
As of the fiscal period ended Tuesday, June 30, 2026. 14.89% below its 12-month average of -38.48%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -44.21%.
RETURN ON INVESTED CAPITAL (ROIC)
-44.21%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-38.48%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-38.14%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-34.92%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-39.38%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-14.89%
CURRENT VS 3Y AVG
-15.91%
CURRENT VS 5Y AVG
-26.61%
CURRENT VS 10Y AVG
-12.27%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.63%
median of 626 covered companies
CURRENT VS SECTOR MEDIAN
-35.50%
vs the sector median at left
Agios Pharmaceuticals, Inc.
Market Cap
$1.88B
Return on Invested Capital (ROIC)
-44.21%
TTM Avg
-38.48%
3Y Avg
-38.14%
5Y Avg
-34.92%
Market Cap
$1.88B
Return on Invested Capital (ROIC)
-36.37%
TTM Avg
8.48%
3Y Avg
-213.38%
5Y Avg
-299.96%
Market Cap
$1.89B
Return on Invested Capital (ROIC)
1.72%
TTM Avg
-1.08%
3Y Avg
-2.19%
5Y Avg
-2.71%
Market Cap
$1.91B
Return on Invested Capital (ROIC)
-1.33%
TTM Avg
-1.10%
3Y Avg
-1.49%
5Y Avg
-1.29%
Market Cap
$1.86B
Return on Invested Capital (ROIC)
-52.66%
TTM Avg
-61.09%
3Y Avg
-54.75%
5Y Avg
-42.45%
Market Cap
$1.84B
Return on Invested Capital (ROIC)
4.13%
TTM Avg
4.21%
3Y Avg
5.71%
5Y Avg
5.17%
Market Cap
$1.84B
Return on Invested Capital (ROIC)
-26.88%
TTM Avg
-21.15%
3Y Avg
-18.76%
5Y Avg
-12.71%
Market Cap
$1.82B
Return on Invested Capital (ROIC)
9.81%
TTM Avg
8.38%
3Y Avg
8.16%
5Y Avg
8.82%
Market Cap
$1.95B
Return on Invested Capital (ROIC)
-6.53%
TTM Avg
-15.76%
3Y Avg
-21.33%
5Y Avg
-21.68%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Agios Pharmaceuticals, Inc. (AGIO) | $1.88B | -44.21% | -38.48% | -38.14% | -34.92% |
| Novavax, Inc. (NVAX)vs › | $1.88B | -36.37% | 8.48% | -213.38% | -299.96% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 1.72% | -1.08% | -2.19% | -2.71% |
| Azenta, Inc. (AZTA)vs › | $1.91B | -1.33% | -1.10% | -1.49% | -1.29% |
| Absci Corporation (ABSI)vs › | $1.86B | -52.66% | -61.09% | -54.75% | -42.45% |
| Astrana Health, Inc. (ASTH)vs › | $1.84B | 4.13% | 4.21% | 5.71% | 5.17% |
| Novocure Ltd (NVCR)vs › | $1.84B | -26.88% | -21.15% | -18.76% | -12.71% |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | 9.81% | 8.38% | 8.16% | 8.82% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.95B | -6.53% | -15.76% | -21.33% | -21.68% |
| AxoGen, Inc. (AXGN)vs › | $1.95B | -4.68% | -2.93% | -9.02% | -10.48% |
ROIC
-44.2%
ROE
-40.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -44.21% |
| 2026-03-31 | -42.23% |
| 2025-12-31 | -38.86% |
| 2025-09-30 | -36.28% |
| 2025-06-30 | -30.85% |
| 2025-03-31 | -27.47% |
| 2024-12-31 | -25.25% |
| 2024-09-30 | -22.56% |
| 2024-06-30 | -57.02% |
| 2024-03-31 | -49.24% |
| 2023-12-31 | -45.04% |
| 2023-09-30 | -40.51% |
| 2023-06-30 | -36.37% |
| 2023-03-31 | -34.22% |
| 2022-12-31 | -33.08% |
| 2022-09-30 | -35.03% |
| 2022-06-30 | -32.79% |
| 2022-03-31 | -30.10% |
| 2021-12-31 | -27.46% |
| 2021-09-30 | -24.67% |
| 2021-06-30 | -20.13% |
| 2021-03-31 | -15.23% |
| 2020-12-31 | -41.27% |
| 2020-09-30 | -38.97% |
| 2020-06-30 | -38.21% |
| 2020-03-31 | -50.97% |
| 2019-12-31 | -53.43% |
| 2019-09-30 | -68.75% |
| 2019-06-30 | -58.59% |
| 2019-03-31 | -49.37% |
| 2018-12-31 | -47.39% |
| 2018-09-30 | -42.19% |
| 2018-06-30 | -36.80% |
| 2018-03-31 | -36.02% |
| 2017-12-31 | -61.76% |
| 2017-09-30 | -48.09% |
| 2017-06-30 | -40.87% |
| 2017-03-31 | -51.47% |
| 2016-12-31 | -37.87% |
| 2016-09-30 | -31.05% |
| 2016-06-30 | -32.92% |
| 2016-03-31 | -39.05% |
| 2015-12-31 | -32.33% |
| 2015-09-30 | -26.18% |
| 2015-06-30 | -14.18% |
| 2015-03-31 | -10.74% |
| 2014-12-31 | -12.57% |
| 2014-09-30 | -16.91% |
| 2014-06-30 | -23.71% |
| 2014-03-31 | -29.85% |
| 2013-12-31 | -23.67% |
| 2013-09-30 | -18.24% |
| 2013-06-30 | -36.59% |
| 2013-03-31 | -27.89% |
| 2012-12-31 | -22.57% |
